Literature DB >> 21406917

Magnetic properties of the Ag-In-rare-earth 1/1 approximants.

Soshi Ibuka1, Kazuki Iida, Taku J Sato.   

Abstract

We have performed magnetic susceptibility and neutron scattering measurements on polycrystalline Ag-In-RE (RE, rare-earth) 1/1 approximants. In the magnetic susceptibility measurements, for most of the RE elements, inverse susceptibility shows linear behaviour in a wide temperature range, confirming well localized isotropic moments for the RE(3 + ) ions. Exceptionally for the light RE elements, such as Ce and Pr, nonlinear behaviour was observed, possibly due to significant crystalline field splitting or valence fluctuation. For RE = Tb, the susceptibility measurement clearly shows a bifurcation of the field-cooled and zero-field-cooled susceptibility at T(f) = 3.7 K, suggesting a spin-glass-like freezing. On the other hand, neutron scattering measurements detect significant development of short-range antiferromagnetic spin correlations in the elastic channel, which is accompanied by a broad peak at [Formula: see text] meV in the inelastic scattering spectrum. These features have striking similarity to those in the Zn-Mg-Tb quasicrystals, suggesting that the short-range spin freezing behaviour is due to local high-symmetry clusters commonly seen in both systems.

Entities:  

Year:  2011        PMID: 21406917     DOI: 10.1088/0953-8984/23/5/056001

Source DB:  PubMed          Journal:  J Phys Condens Matter        ISSN: 0953-8984            Impact factor:   2.333


  2 in total

1.  A family of binary magnetic icosahedral quasicrystals based on rare earths and cadmium.

Authors:  Alan I Goldman; Tai Kong; Andreas Kreyssig; Anton Jesche; Mehmet Ramazanoglu; Kevin W Dennis; Sergey L Bud'ko; Paul C Canfield
Journal:  Nat Mater       Date:  2013-06-09       Impact factor: 43.841

2.  Magnetism in icosahedral quasicrystals: current status and open questions.

Authors:  Alan I Goldman
Journal:  Sci Technol Adv Mater       Date:  2014-07-02       Impact factor: 8.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.